Video Experimental Relacionado

Updated: Jul 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Los nucleósidos de fosfonato de desoxitrreosilo como agentes selectivos contra el VIH

Tongfei Wu¹, Matheus Froeyen, Veerle Kempeneers

¹Laboratories of Medicinal Chemistry and Virology, Rega Institute for Medical Research, Minderbroedersstraat 10, Leuven, Belgium.

Journal of the American Chemical Society

|April 7, 2005

Resumen

Dos nuevos nucleósidos de fosfonatos, PMDTA y PMDTT, demuestran una potente actividad anti-VIH sin toxicidad observada. Su incorporación al ADN por la transcriptasa inversa del VIH-1 sugiere potencial como agentes antivirales.

Área de la Ciencia:

Química Medicinal La Química Medicinal es el campo de la Química Medicinal.
Virología Virología.
Biología Molecular Biología Molecular

Sus antecedentes:

El desarrollo de nuevos agentes antivirales es crucial para combatir las infecciones por VIH-1.
Los nucleósidos fosfonados son una clase de compuestos explorados por su potencial terapéutico.

Objetivo del estudio:

Para sintetizar y evaluar nuevos nucleósidos fosfonatos derivados de l-treosa y l-2-deoxitreosa para la actividad anti-VIH.
Investigar el mecanismo de acción de compuestos prometedores, incluida su incorporación al ADN.

Principales métodos:

Síntesis de ocho nuevos nucleósidos de fosfonato.
Ensayos de actividad anti-VIH-1 y anti-VIH-2 in vitro.
Evaluaciones de citotoxicidad.
Estudios enzimáticos sobre la cinética de la incorporación del ADN utilizando la transcriptasa inversa del VIH-1 y la ADN polimerasa alfa.

Principales resultados:

Dos compuestos, PMDTA y PMDTT, exhibieron una potente actividad anti-VIH-1 (VIH-2) con valores de EC50 de 2.53 microM y 6.59 microM, respectivamente.
No se observó citotoxicidad a altas concentraciones (CC50 > 316 microM para PMDTA, > 343 microM para PMDTT).
El difosfato de PMDTA fue incorporado al ADN por la transcriptasa inversa del VIH-1 con cinética similar a la dATP y fue mal utilizado por la ADN polimerasa alfa, lo que indica una incorporación selectiva.

Conclusiones:

PMDTA y PMDTT son agentes anti-VIH prometedores con perfiles de seguridad favorables.
La incorporación selectiva de PMDTA en el ADN por la transcriptasa inversa del VIH-1 destaca su potencial como terapia antiviral dirigida.
El ajuste estructural de PMDTA dentro del sitio activo de la transcriptasa inversa del VIH-1 apoya su mecanismo de acción.

Más Videos Relacionados

Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication

Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication

Published on: June 14, 2024

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Videos de Conceptos Relacionados

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...